Literature DB >> 33112893

Risk factors for surgical site infections using a data-driven approach.

J M van Niekerk1,2,3, M C Vos3, A Stein2, L M A Braakman-Jansen1, A F Voor In 't Holt3, J E W C van Gemert-Pijnen1.   

Abstract

OBJECTIVE: The objective of this study was to identify risk factors for surgical site infection from digestive, thoracic and orthopaedic system surgeries using clinical and data-driven cut-off values. A second objective was to compare the identified risk factors in this study to risk factors identified in literature. SUMMARY BACKGROUND DATA: Retrospective data of 3 250 surgical procedures performed in large tertiary care hospital in The Netherlands during January 2013 to June 2014 were used.
METHODS: Potential risk factors were identified using a literature scan and univariate analysis. A multivariate forward-step logistic regression model was used to identify risk factors. Standard medical cut-off values were compared with cut-offs determined from the data.
RESULTS: For digestive, orthopaedic and thoracic system surgical procedures, the risk factors identified were preoperative temperature of ≥38°C and antibiotics used at the time of surgery. C-reactive protein and the duration of the surgery were identified as a risk factors for digestive surgical procedures. Being an adult (age ≥18) was identified as a protective effect for thoracic surgical procedures. Data-driven cut-off values were identified for temperature, age and CRP which can explain the SSI outcome up to 19.5% better than generic cut-off values.
CONCLUSIONS: This study identified risk factors for digestive, orthopaedic and thoracic system surgical procedures and illustrated how data-driven cut-offs can add value in the process. Future studies should investigate if data-driven cut-offs can add value to explain the outcome being modelled and not solely rely on standard medical cut-off values to identify risk factors.

Entities:  

Mesh:

Year:  2020        PMID: 33112893      PMCID: PMC7592760          DOI: 10.1371/journal.pone.0240995

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

Surgical site infections (SSI), as defined by the European Centre for Disease Prevention and Control (ECDC) [1], make up 19.6% of the total number of healthcare-associated infections (HAIs) in Europe. With an estimated 81 089 patients in Europe having an HAI on any given day, almost 16 000 people in Europe are suffering from some form of SSI at any given time [2]. The burden of SSI can be measured in terms of increased length of stay in hospital, additional (surgical) procedures required, increased morbidity and mortality, as well as in economic terms [3]. Risk factors relating to the patient, procedure and the environment alter the odds of an SSI occurring. Research has been done to identify risk factors for SSI with the aim to identify preventative actions to reduce the incidence rate of SSI [4-10]. Patient-related risk factors for SSI, such as obesity, diabetes, surgery duration and the American Society of Anaesthesiologists (ASA) score are risk factors for digestive system, thoracic and orthopaedic surgical procedures [11-22]. Risk factors in low-income countries also include unemployment and level of education due to the disparity in socioeconomic status [14]. Risk factors can be modifiable or non-modifiable [23]. Modifiable risk factors are most interesting of the two since they can be changed preoperatively to reduce the risk of SSI. The Segmentation of surgical procedures into homogenous groups makes it possible to find useful and relevant risk factors unique to each segment. Digestive system surgical procedures are more prone to SSI as they are generally clean-contaminated or dirty surgeries which make deep space SSI more likely. The occurrence of SSI after thoracic and orthopaedic surgeries are both relatively low because they are both typically clean surgeries, but the probability of attracting a deep space SSI after thoracic surgery is much higher compared to orthopaedic surgeries [15]. Because of these differences, we focus on digestive system, thoracic and orthopaedic surgical procedures for this study. Multivariate logistic regression is the most common statistical model used to identify risk factors in longitudinal study design data [16]. Not all studies report the discriminatory power of the multivariate logistic regression model fitted. Risk factor identification studies do not usually specify how continuous variables cut-offs are determined. Cut-off values for variables such as age (≥18) or patient temperature (37°C) may seem intuitive or standard for clinical practice, but they may not statistically be the best cut-offs values determined by the data [17]. The objective of this study is to identify risk factors for SSI from digestive, thoracic and orthopaedic system surgeries using clinical and data-driven cut-off values. A second objective is to compare the identified risk factors in this study to risk factors identified in the literature.

Materials and methods

Literature search

A literature search was performed to identify known risk factors for SSI associated with digestive system surgical procedures, thoracic surgery and orthopaedic procedures using the corresponding medical subject headings (MeSH) linked data representation and the MEDLINE database. Search strings used for MEDLINE literature search: “Surgical Wound Infection”[Mesh] AND “Risk Factors”[Mesh] AND “Digestive System Surgical Procedures”[Mesh] “Surgical Wound Infection”[Mesh] AND “Risk Factors”[Mesh] AND “Orthopaedic Procedures”[Mesh] “Surgical Wound Infection”[Mesh] AND “Risk Factors”[Mesh] AND “Thoracic Surgery”[Mesh] The search results were sorted, using the Best Match algorithm [18] developed by PubMed. Search results were deemed relevant using title and abstract screening. Risk factors were extracted if they were significant in a multivariable analysis until data saturation was achieved [19]. Risk factors identified, which were common to all three groups of surgeries, were defined as “general risk factors” in this study.

Setting and data collection

The Erasmus MC University Medical Centre in Rotterdam is the largest university medical hospital in the Netherlands with more than 1 300 beds [15]. The data used for this study were anonymised in accordance with the Dutch Personal Data Protection Act (WBP). Approval from the Medical Ethical Research Committee was obtained (MEC-2018-1185). A weekly prevalence survey was performed by infection control practitioners (ICP) from January 2013 until December 2013 and two-weekly until June 2014 using a semi-automated algorithm proposed by Streefkerk et al. [20, 21]. This algorithm was used to calculate a nosocomial infection index (NII) which was then verified by ICP in case of a positive outcome to determine whenever an HAI was present or not. An ICP verified all patients with an NII > 7, and a definite SSI outcome was concluded by the ICP using the electronic patient data system. This outcome was used in this study as the occurrence of SSI outcome variable. Data were extracted from a centralised database, containing cross-departmental data, clinical synopsis reports, infectious disease consultation reports, laboratory results and imaging reports. Data regarding the prescription of antimicrobials, in the J01 class of the Anatomical Therapeutic Chemical (ATC) classification system [22], were also included. Surgeries were included if they were part of the three groups of surgeries under investigation in this study and had a point prevalence measurement within 30 days after the surgery took place. If a second surgery took place within 30 days after an included surgery, then the recent surgery was excluded. All emergency surgeries were excluded to avoid possible undesirable confounding effects relating to the urgency and necessity of the surgeries.

Statistical analysis

The differences in the averages of variables with missing values and those without were evaluated using t-tests and were found statistically significant. These tests, together with Little’s MCAR test, convinced us that the missing values were not completely randomly missing and that we could not make use of more simple imputation methods. Therefore, we chose to use conditional Markov chain Monte Carlo (MCMC) with multiple imputations for the imputation process [24, 25]. Two methods were used to discretise continuous measurement variables: 1) standard medical cut-offs as used by Erasmus MC and 2) recursive partitioning [17]. Recursive partitioning is a data-driven, supervised discretisation method, used to group continuous values with similar outcomes optimally. The data-driven method was used to test and confirm if the standard medical cut-offs were the best way to explain the outcome variable for the groups of surgical procedures considered. To build a prognostic prediction model for SSI, Hosmer et al. suggest fitting a univariate logistic regression model to each variable separately and if the p-value is less than a specific p-value, 0.1 is this case, then consider the variable good enough to include in the multivariate logistic regression model [26]. A univariate analysis was performed for each of the three groups of surgeries using the variables identified from the literature search. Significant variables (p<0.1) in the univariate analysis were added to the list of variables associated with each group of surgery, together with the variables identified from the literature search. This resulted in an extended list of general risk factors as more risk factors were common across the three groups of surgeries. A multivariate logistic regression model was built using a forward stepwise approach for each of the three groups of surgeries [27]. The general risk factors were first added to the model and then the risk factors unique to each surgery group in the order of the Akaike information criterion (AIC) until convergence was reached. In this case, we chose the conversion of the model to imply that there are no additional variables which can be added which will be statistically significant with a p-value of less than 0.05 or an AIC of 3.8415. Model performance was determined using the Gini coefficient after each step of the multivariate model, and the difference is reported as the marginal contribution of surgery group-specific risk factors for this study [19, 28]. Model performance was cross-validated using 5-fold cross-validation to estimate how the model would perform on new data [29]. R [30] was used in this study together with packages mice (multiple imputation) [31], smbinning (recursive partitioning) [32], dplyr (data wrangling) [33], finalfit (formatting of tables) [34] and scorecard (cross-validation) [35]. Approval was obtained from the Medical Ethical Committee of Erasmus MC (MEC-2018-1185) to perform this study. Data were analysed anonymously, and thus no further consent was obtained.

Results

The literature search resulted in 1 422 research papers (as at 5 March 2020) using the MeSH headings in the PubMed search engine. We identified 24 research papers, published from 2008 until 2019, which contained statistically significant results from a multivariate analysis. A total of 79 risk factors were identified for the three groups of surgical procedures [11–13, 16, 23, 36–54] (S1 Table). Age, ASA class, body mass index (BMI), preoperative length of stay and diabetes were identified as general risk factors from the literature search. In total, 29 risk factors for digestive system surgical procedures, 31 for orthopaedic procedures and 19 for thoracic surgeries were identified. This amounted to 59 unique risk factors, of which 15 were present in more than one group of surgeries.

Risk factor identification

A total of 21 of the 59 unique risk factors could be replicated using our own data. The variable describing the type of surgery was used to create three homogenous groups of surgical procedures. The emergency classification variable was used to exclude emergency surgeries from the study such that 19 risk factors remained (Table 1). We observed 3 250 surgeries over the study period and excluded 526 (16.2%) emergency surgeries to be left with 2 724 surgical observations. CRP and temperature data were available for 52.55% (60.47% for in-patients) and 96.88% of all surgeries respectively.
Table 1

Variable names and definitions used to investigate the occurrence of SSI in this study.

VariableSurgery groupDefinition
Demographic
    GenderD,OGender of patient (Male/Female)
    AgeD,O,TAge of patient on the day of surgery (Years)
    ASA classD,O,TASA class of patient (I-V)
    BMID,O,TBMI of patient at the time of surgery.
Behavioural
    Alcohol useOAlcohol use of patient at the time of surgery (Current/Never/Past).
    SmokingD,OSmoking status of patient at the time of surgery (Current/Never/Past).
Comorbidities
    Heart diseaseO,TPatient has a history of heart disease at the time of surgery (Yes/No).
    Liver diseaseDPatient has a history of liver disease at the time of surgery (Yes/No).
    HypertensionOPatient has a history of hypertension (Yes/No).
    DiabetesD,O,TPatient has diabetes Type I or II at the time of surgery (Yes/No).
Measurement
    TemperatureDHighest temperature of patient in the past 7 days before surgery.
    CRPOHighest CRP of patient in the 7 days before surgery.
    LeukocyteDHighest leukocyte level of patient in the 7 days before surgery.
    Serum total proteinDHighest serum total protein of patient in the 7 days before surgery.
    GlucoseDHighest glucose level of patient in the 7 days before surgery.
    HaemoglobinDHighest haemoglobin level of patient in the 7 days before surgery.
Operative
    Preoperative length of stayD,O,TPreoperative length of hospital stay of patient at the time of surgery (Days).
    Antibiotic useTAntibiotic (WHO ATC code J01 [22]) use of patient at the time of surgery (Yes/No).
    Duration of surgeryD,ODuration of the surgical procedure (Minutes).

D, Digestive system surgical procedures; O, Orthopaedic system surgical procedures; T, Thoracic system surgical procedures; ASA, American Society of Anaesthesiologists; CRP, C-reactive protein; BMI, Body Mass Index; SSI, Surgical Site Infection; ATC, Anatomical Therapeutic Chemical; WHO, World Health Organization.

D, Digestive system surgical procedures; O, Orthopaedic system surgical procedures; T, Thoracic system surgical procedures; ASA, American Society of Anaesthesiologists; CRP, C-reactive protein; BMI, Body Mass Index; SSI, Surgical Site Infection; ATC, Anatomical Therapeutic Chemical; WHO, World Health Organization. The significant univariate results of digestive system, orthopaedic and thoracic surgical procedures are shown in Table 2. Antibiotic use, CRP and temperature were added to the list of general risk factors after being found statistically significant in the univariate analysis–increasing the number of general risk factors to 8. Diabetes was identified as a general risk factor from our literature search but was not found significant in any of the three univariate analyses in our own study. For digestive system surgical procedure and thoracic procedures, the data-driven cut-off for age was obtained as 23 years and both the standard cut-off (18 years) and the data-driven cut-off were statistically significant with p-values of less than 0.001 which resulted in rejecting the null hypothesis that the coefficient associated with the age of the patient is zero. For orthopaedic procedures, the data-driven cut-off for the temperature (39 degrees) was found statistically significant, but the standard medical cut-off not. A data-driven CRP cut-off of 8.1 was identified for orthopaedic surgical procedures as opposed to a standard medical CRP cut-off of 10; both cut-offs are statistically significant.
Table 2

Digestive system surgical procedures: univariate analysis of risk factors for the future occurrence of SSI.

VariableSSI = No (2 600)SSI = Yes (124)Univariate OR (95%CI, P-value)
Digestive System Surgical Procedures
GenderFemale359 (43.9)224 (33.8)Reference
Male458 (56.1)47 (66.2)1.54 (0.93–2.60, p = 0.099)
Age1≤18246 (30.1)8 (11.3)Reference
>18571 (69.9)63 (88.7)3.39 (1.70–7.77, p<0.001)
Age (data-driven)≤23258 (31.6)8 (11.3)Reference
>23559 (68.4)63 (88.7)3.63 (1.82–8.32, p<0.001)
Antibiotic useNo496 (60.7)17 (23.9)Reference
Yes321 (39.3)54 (76.1)4.91 (2.85–8.86, p<0.001)
Temperature1≤36.50 (0.0)0 (0.0)NA
(36.5,37.5]98 (12.0)2 (2.8)Reference
>37.5719 (88.0)69 (97.2)4.70 (1.44–28.91, p = 0.033)
Temperature (data-driven)≤38535 (65.5)20 (28.2)Reference
(38,39]187 (22.9)25 (35.2)3.58 (1.95–6.66, p<0.001)
>3995 (11.6)26 (36.6)7.32 (3.94–13.79, p<0.001)
CRP1≤10397 (48.6)21 (29.6)Reference
>10420 (51.4)50 (70.4)2.25 (1.35–3.89, p = 0.003)
CRP (data-driven)≤8.1365 (44.7)18 (25.4)Reference
>8.1452 (55.3)53 (74.6)2.38 (1.39–4.24, p = 0.002)
Preoperative length of stay (Days)Mean Days (SD)6.6 (24.1)12.1 (37.3)1.01 (1.00–1.01, p = 0.092)
Duration of surgeryMean Minutes (SD)243.6 (143)330.4 (190.8)1.00 (1.00–1.01, p<0.001)
Orthopaedic Procedures
ASA classASA CLASS I196 (26.8)6 (33.3)
ASA CLASS II339 (46.4)6 (33.3)0.58 (0.18–1.87, p = 0.348)
ASA CLASS III182 (24.9)4 (22.2)0.72 (0.18–2.55, p = 0.612)
ASA CLASS ≥ IV13 (1.8)2 (11.1)5.03 (0.69–24.47, p = 0.062)
Alcohol useCurrent327 (44.8)6 (33.3)Reference
Never339 (46.4)8 (44.4)1.29 (0.44–3.94, p = 0.645)
Past64 (8.8)4 (22.2)3.41 (0.85–12.26, p = 0.063)
Antibiotic useNo591 (81.0)8 (44.4)Reference
Yes139 (19.0)10 (55.6)5.31 (2.06–14.16, p<0.001)
Temperature (data-driven)≤39695 (95.2)14 (77.8)Reference
>3935 (4.8)4 (22.2)5.67 (1.55–16.79, p = 0.003)
Thoracic Surgery
Age1≤18232 (22.0)16 (45.7)Reference
>18821 (78.0)19 (54.3)0.34 (0.17–0.67, p = 0.002)
Age (data-driven)≤23226 (21.5)16 (45.7)Reference
>23827 (78.5)19 (54.3)0.32 (0.16–0.65, p = 0.001)
BMIMean (SD)24.5 (5.3)22.1 (4.2)0.91 (0.85–0.98, p = 0.010)
Alcohol useCurrent534 (50.7)11 (31.4)Reference
Never422 (40.1)18 (51.4)2.07 (0.98–4.57, p = 0.061)
Past97 (9.2)6 (17.1)3.00 (1.01–8.09, p = 0.034)
Antibiotic useNo705 (67.0)18 (51.4)Reference
Yes348 (33.0)17 (48.6)1.91 (0.97–3.77, p = 0.060)
Temperature1≤36.50 (0.0)0 (0.0)NA
(36.5,37.5]302 (28.7)3 (8.6)Reference
>37.5751 (71.3)32 (91.4)4.29 (1.52–17.94, p = 0.017)
Temperature (data-driven)≤38882 (83.8)20 (57.1)Reference
>38171 (16.2)15 (42.9)3.87 (1.91–7.67, p<0.001)
CRP1≤10684 (65.0)17 (48.6)Reference
>10369 (35.0)18 (51.4)1.96 (1.00–3.88, p = 0.050)
Haemoglobin1≤8.6665 (63.2)21 (60.0)Reference
(8.6,10.5]358 (34.0)11 (31.4)0.97 (0.45–2.00, p = 0.942)
 >10.530 (2.8)3 (8.6)3.17 (0.72–9.85, p = 0.074)

CRP, C-reactive protein; OR, Odds Ratio; BMI, Body Mass Index; NA, Not Applicable; CI, Confidence Interval; SSI, Surgical Site Infection; OR, Odds ratio; Data-driven, cut-off values determined using recursive partitioning.

1Standard Erasmus MC clinical cut-offs.

2The percentage distribution of the SSI outcome is provided in brackets next to the frequency for each variable.

CRP, C-reactive protein; OR, Odds Ratio; BMI, Body Mass Index; NA, Not Applicable; CI, Confidence Interval; SSI, Surgical Site Infection; OR, Odds ratio; Data-driven, cut-off values determined using recursive partitioning. 1Standard Erasmus MC clinical cut-offs. 2The percentage distribution of the SSI outcome is provided in brackets next to the frequency for each variable. The multivariate results using standard medical cut-offs and data-driven cut-offs are shown in Tables 3 and 4, respectively. The temperature variable was statistically significant in the multivariate analysis using the data-driven cut-offs for all three groups of surgeries, but not in one of the multivariate analysis using the medical standard cut-offs. The duration of the surgery was the only statistically significant variable in the multivariate analyses which was not identified as a general risk factor to increase the odds of SSI by approximately 6% for every 30 minutes spent in surgery. For digestive surgical procedures, the addition of duration of surgery to the multivariate model increased the Gini coefficient from 0.46 to 0.52 based on standard medical cut-offs and from 0.57 to 0.62 for the multivariate model based on the data-driven cut-offs. This increase translates into a 12.5% and 8.8% increase in the Gini coefficient, respectively. Neither the orthopaedic nor the thoracic group of surgical procedures had any statistically significant risk factors which are not part of the general risk factors group of surgeries. The Gini coefficient of the data-driven multivariate model is 19.5% (0.62 vs 0.52) higher than the multivariate model based on the standard medical cut-offs. The 5-fold cross-validated 95% confidence intervals for the Gini coefficients based on the validation samples of the data-driven models are (0.49, 0.72) for digestive procedures, (0.21, 0.86) for orthopaedic procedures and (0.21,0.70) for thoracic procedures.
Table 3

Multivariate analysis risk factors for the occurrence of SSI by group of surgeries using standard medical cut-offs.

Risk factor by surgery group1CoefficientMultivariate OR (95%CI)P-value
Digestive System Surgical Procedures
    Antibiotic use1.2403.455 (1.951–6.384)<0.001
    Duration of surgery (Minutes)0.0031.003 (1.001–1.004)<0.001
    CRP >100.8032.232 (1.302–3.951)0.004
Orthopaedic Surgical Procedures
    Antibiotic use1.6705.315 (2.059–14.158)<0.001
Thoracic Surgical Procedures
    Age >18-4.1950.146 (0.058–0.351)<0.001
    Antibiotic use1.3114.849 (2.035–12.266)<0.001

CRP, C-reactive protein; CI, Confidence Interval; OR, Odds ratio.

1The multivariate analysis was performed using Erasmus MC clinical cut-offs.

Table 4

Multivariate analysis risk factors for the occurrence of SSI by group of surgeries using data-driven cut-offs.

Risk factor by surgery group1CoefficientMultivariate OR (95%CI)P-value
Digestive System Surgical Procedures
    Temperature [38,39]1.0672.907 (1.556–5.497)<0.001
    Temperature >391.7325.650 (2.952–10.947)<0.001
    Antibiotic use1.2013.322 (1.856–6.200)<0.001
    Duration of surgery (Minutes)0.0021.002 (1.001–1.004)0.003
    CRP >8.10.6391.894 (1.062–3.510)0.035
Orthopaedic Surgical Procedures
    Antibiotic use1.5523.665 (1.370–10.006)0.009
    Temperature >391.2245.120 (1.316–16.387)0.009
Thoracic Surgical Procedures
    Age >17-1.8470.158 (0.055–0.426)<0.001
    Antibiotic use1.5974.939 (1.896–14.043)0.002
    Temperature >380.8242.280 (1.098–4.653)0.024

Data-driven, cut-off values determined using recursive partitioning; CRP, C-reactive protein; CI, Confidence Interval; OR, Odds ratio.

1The multivariate analysis was performed using data-driven cut-offs.

CRP, C-reactive protein; CI, Confidence Interval; OR, Odds ratio. 1The multivariate analysis was performed using Erasmus MC clinical cut-offs. Data-driven, cut-off values determined using recursive partitioning; CRP, C-reactive protein; CI, Confidence Interval; OR, Odds ratio. 1The multivariate analysis was performed using data-driven cut-offs. An overview of the study results (Table 5) shows that 10 of the 19 risk factors, identified during the literature search, were not statistically significant in the univariate or multivariate analysis for any of the surgery groups. BMI and diabetes were identified across all three groups of surgeries and multiple studies as risk factors for SSI but were not statistically significant in this study. Temperature and the duration of the surgery were confirmed as risk factors for digestive system surgeries, and similarly, antibiotic use and age were confirmed as risk factors for thoracic surgeries. Antibiotic use and CRP were identified as risk factors for digestive surgeries from the multivariate analysis, which were identified during the literature search for thoracic and orthopaedic surgeries, respectively. Antibiotic use and temperature were statistically significant for all three groups of surgeries and were included because of two studies regarding thoracic and digestive system surgeries, respectively [40, 55].
Table 5

Statistical significance of risk factors and the source which lead them to be considered by surgical procedure.

Risk FactorSignificance1Digestive System2Orthopaedic2Thoracic2
AgeDU,TM[38, 11, 43, 47][16][12]
Alcohol useOU,TU[51]
Antibiotic useDM,OM,TM[40]
ASA ClassOU[37, 39, 41, 43, 54][16, 51, 53][16]
BMINone[44][5153][42]
CRPDM[16]
DiabetesNone[38, 47, 50][16, 45, 51, 53][13]
Duration of surgeryDM[36, 38, 41, 43, 44, 49, 54][16, 45, 51, 53]
GenderDU[38, 11, 43][16, 51]
GlucoseNone[47]
HaemoglobinNone[11, 44, 54]
Heart DiseaseNone[51][12]
HypertensionNone[51]
LeukocyteNone[55]
Liver diseaseNone[54]
Preoperative length of stayDU[41, 50][16, 52][12, 13, 40]
Serum total proteinNone[36, 49]
SmokingNone[49][5153]
TemperatureDM,OM,TM[55]

D, Digestive system surgical procedures; O, Orthopaedic system surgical procedures; U, Significant in univariate analysis; M, Significant in multivariate analysis; T, Thoracic system surgical procedures; ASA, American Society of Anaesthesiologists; CRP, C-reactive protein; SSI, Surgical Site Infection; BMI, Body Mass Index.

1During which part of the analysis the risk factor was found statistically significant.

2References to the literature which had the risk factor as a multivariate result for each group of surgeries.

D, Digestive system surgical procedures; O, Orthopaedic system surgical procedures; U, Significant in univariate analysis; M, Significant in multivariate analysis; T, Thoracic system surgical procedures; ASA, American Society of Anaesthesiologists; CRP, C-reactive protein; SSI, Surgical Site Infection; BMI, Body Mass Index. 1During which part of the analysis the risk factor was found statistically significant. 2References to the literature which had the risk factor as a multivariate result for each group of surgeries.

Discussion

We identified temperature and antibiotics used at the time of surgery as risk factors for digestive, orthopaedic and thoracic system surgical procedures in this study. The duration of the surgery was identified as a risk factor for digestive surgical procedures. Being an adult (age ≥ 18) was identified as a protective effect for thoracic surgical procedures. Data-driven cut-offs were identified for temperature, CRP and age, which differ from the standard medical cut-offs. Temperature would not have been identified as a risk factor if only standard medical cut-offs were considered. From our literature search, we identified age, ASA class, BMI, preoperative length of stay and diabetes as general risk factors, while CRP, temperature and antibiotic use were identified as general risk factors because of this study. The identified risk factors may be classified as modifiable or non-modifiable, depending upon the circumstances of the patient like the complexity of his condition. For instance, the temperature of a patient may be high because of an existing infection, which is why the surgery is needed in the first place and may not be modifiable before surgery. Age, on the other hand, may be a modifiable risk factor if the surgery can be postponed for several years, e.g. due to a heart defect. This study revealed that children are more likely to be diagnosed with an SSI after thoracic surgery than adults. There are studies which identify risk factors for children after thoracic surgeries, but none found that being a child is a risk factor for SSI [42, 48] after undergoing thoracic surgery. We segmented the thoracic surgeries between adults and children and obtained multivariate results for children and adults separately. The multivariate model based only on children (age ≤ 18) did not reveal any significant results, contrary to the results of the thoracic study which found age to be a risk factor for children [12]. This absence could be partly due to the small study population size of 248. Antibiotic usage was the only significant factor in the multivariate analysis of thoracic surgeries based on adults. The other two groups of surgical procedures were consistent in terms of their statistical significance of risk factors based on adults. The data-driven cut-offs confirmed the existing standard medical cut-offs. On average the clinical cut-off for temperature was one degree Celsius lower, while for digestive system surgical procedures, the clinical cut-off for CRP (10) was just less than two units more than the data-driven cut-off of 8.1. This means that there is a greater difference between the occurrence of SSI for patients with a CRP below and above 8.1 than below and above 10. The data-driven cut-offs improved the ability of the statistical model to explain the occurrence of SSI. The performance of the digestive system surgical procedure prediction model increased by 19.5% due to using data-driven cut-offs rather than the standard medical cut-offs. Using data-driven cut-offs, we were able to identify temperature as a risk factor for all three groups of surgical procedures. If standard clinical cut-offs were used, temperature would not have been significant from the multivariate analysis. This potential oversight illustrates the importance of evaluating the cut-offs used for continuous variables against the data before identifying risk factors. Antibiotic use, temperature and CRP were added to the list of general risk factors by incorporating the statistically significant results of the univariate analysis. These risk factors might have been overlooked when the focus was on only one type of surgery. Temperature was identified as a risk factor in the multivariate results for all three groups of surgical procedures, whereas the literature search identified it only for digestive surgeries. Antibiotic use was not found during our literature search for digestive or orthopaedic surgical procedures but was found significant for both groups of surgeries in the multivariate analysis of our study. The Centres for Disease Control and Prevention (CDC), the European centre for disease prevention and control (ECDC), World Health Organisation (WHO) and Netherlands National Institute for Public Health and the Environment (RIVM) suggest maintaining normothermia intraoperatively to prevent undesirable hypothermia (during some thoracic and neurosurgeries, hypothermia may be desirable). [56-58] A lower intraoperative bound for temperature of 35.5°C to 36°C is explicitly mentioned, and only the RIVM mention an upper bound of 38°C which is consistent with the risk factors identified in our study. An upper limit for preoperative temperature should, therefore, be investigated instead of only the lower limit. The four health organisations refer to the proper administration and timing of surgical antimicrobial prophylaxis, but not to the proper preoperative use of standard prescription antibiotics. Systemic antibiotics are typically prescribed to stabilise patients before undergoing surgery. A possible explanation for the increased occurrence of SSI associated with antimicrobials prescribed before surgery could be that these patients were not completely stabilised before surgery which increased their risk of SSI. The proper preoperative use of antibiotics should be well defined, and the reason why antibiotic-use was identified as a risk factor for SSI should be further investigated.

Limitations

This is a retrospective, single-centre study, and therefore the data were not collected for the purpose of this study. Even though cross-validation was performed to estimate model performance on new data, the models were not externally validated. Surgeries were aggregated into three broad groups of surgical procedures which serve as a proxy for the reason for surgery but leads to the loss of information regarding the exact reasons for the surgery. Some measurements, like temperature and CRP, were not always present and was partly overcome using imputation. Patient information concerning smoking and drinking habits may be understated due to incomplete medical records. The literature search used for this study was not exhaustive but rather based on the principal on data saturation. A comprehensive list of variables related to the nutritional and immunological alterations of the patients was not included in the analyses as they were not available from the data. We used a 30-day outcome period in which we observe if an SSI was present or not, but according to the CDC definition, this outcome period should be one year for surgical implantation procedures. Since our data only spans over 18 months, it was not possible to use a 12-month outcome window for all surgical implantation procedures, which is a limitation of this study. The administration of prophylaxis and the optimal timing thereof is an important risk factor for the occurrence of SSI. However, these data were not available.

Future work

Future work will investigate the modifiability of the risk factors identified in this study in more detail, as the circumstances under which this occurs are hitherto unclear. The exact purpose of the use of antibiotics over the time of surgery was not investigated in depth, which can be done in future studies. Future research can also investigate differences between adults and children, which lead to the occurrence of SSI among children. Another opportunity for future research is to investigate which risk factors are predictive for the occurrence of SSI over different periods. Doing this will enable healthcare workers to identify which risk factors explain the occurrence of SSI soon after surgery, towards the end of the 30 days and even later for implantation surgeries. These insights can help set guidelines to determine the vigilance necessary to mitigate the risk of SSI on a patient level.

Conclusion

This study shows that data-driven cut-offs can be used to identify risk factors which would not have been identified by only using standard medical cut-offs. Preoperative temperature and antibiotic use were identified as risk factors for digestive, orthopaedic, thoracic system surgeries, while the duration of surgery and age were identified as risk factors for orthopaedic and thoracic system surgeries, respectively. In contrast with literature, this study found that an SSI is more likely to occur in children (age < 18) than in adults after thoracic system surgeries. Statistical modelling has been important to quantify important risk factors and indicate their significance. Clinical studies using retrospective data are important to carry out, despite limitations in the data sets. To this end, future studies should use both standard medical cut-offs and data-driven cut-offs to investigate risk factors.

Risk factors identified from multivariate analysis during literature search.

(DOCX) Click here for additional data file.

The multivariate logistic regression equations based on the data-driven cut-offs.

(DOCX) Click here for additional data file. 16 Jun 2020 PONE-D-20-14495 Risk factors for surgical site infections using a data-driven approach PLOS ONE Dear Dr. van Niekerk, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jul 31 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript: A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Francesco Di Gennaro Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. We note that you have provided information about your ethics approval and data anonymization in the Ethics Statement. We ask that you additionally provide this information in your Methods section. 3.  We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: In this work, Authors conducted a robust data-driven approach to identify risk factors for surgical site infections after digestive system, orthopedic or thoracic surgery procedures. Overall, the work is well written and clear. The statistical analysis is appropriate and well performed. The major limitation of this work is the lack of certain information that could have influenced the final result of multivariable analysis. However, this work is worth for publication after few minor revisions Introduction 1) Lines 48-49: Many research have been conducted until now in order to identify risk factors for SSI. However, one important point often overlooked is the importance of clinical setting. Indeed, risk factors for SSI could importantly differ between low income countries and high income countries. A recent interesting work addressed this topic (Di Gennaro F, et al. Maternal caesarean section infection (MACSI) in Sierra Leone: a case-control study. Epidemiol Infect . 2020 Feb 27;148:e40. doi: 10.1017/S0950268820000370.) and could be cited, along with a brief paragraph discussing this point. Discussion 1) The antibiotic use as a risk factor for SSI is interesting but controversial. In fact, although many guidelines suggest to limit the use of the antibiotic prophylaxis at the day of the surgery, often antibiotics are prescribed several days before and after the surgical day. In my opinion Authors should give a possible explanation for this very important result possibly based on their data. 2) Did any data regarding the reason for surgical procedures were available? It is widely accepted that the cause of surgical procedure (infection, cancer, prosthetic implantation, etc) and the general clinical condition of patient (immunocompromised, severely undernourished, etc) are significant predictors of SSI. If these information are not available, this point should be included among limitations. Reviewer #2: In this manuscript Johan Magnus van Niekerk and co-authors tried to identify major risk factors for surgical site infections from digestive, thoracic and orthopaedic system surgeries. To reach this aim they previously identified some known risk factors in literature and then they compared them with data extrapolated from a database of a large tertiary care hospital in the Netherlands. This study could give an important contribution on prevention of surgical site infection by identifying modifiable risk factors and subsequently preventative actions. The title and abstract are appropriate for the content of the text. There are my comments sorted by section. Methods: • line 93: I think that could be useful to clarify how the nosocomial infection index was obtained, in particular which parameters where included to determine it. • Line 192-205: I think that this paragraph should be removed. It appears too technical and probably not necessary for the purpose of the article. Discussion: • Lines 240-241: when you talk about antibiotic usage before surgery do you refer to their use in a broad sense or there are particular class of antibiotics related to a major risk? It could be interesting to examine which classes are related to a major risk for SSI. • Lines 256-257: there is a repetition, you just defined the general risk factors in lines 225-228 ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. 21 Sep 2020 Response to reviewers – PONE-D-20-14495 Risk factors for surgical site infections using a data-driven approach Johan Magnus van Niekerk, Margreet C. Vos, Alfred Stein, Annemarie Braakman-Jansen, Anne F. Voor in ’t holt, Lisette van Gemert-Pijnen We are grateful for your valuable comments which helped us to improve our manuscript. We sincerely appreciate the time you spent reviewing this manuscript. We revised our manuscript in accordance with your comments. Please find our responses to the comments below. Reviewer #1: Introduction 1. Lines 48-49: Many research have been conducted until now in order to identify risk factors for SSI. However, one important point often overlooked is the importance of clinical setting. Indeed, risk factors for SSI could importantly differ between low income countries and high income countries. A recent interesting work addressed this topic (Di Gennaro F, et al. Maternal caesarean section infection (MACSI) in Sierra Leone: a case-control study. Epidemiol Infect . 2020 Feb 27;148:e40. doi: 10.1017/S0950268820000370.) and could be cited, along with a brief paragraph discussing this point. We welcome this suggestion and consider the introduction as more rounded because of this addition. The following text was added to the introduction, and the suggested research article cited: L51 – L53: “Risk factors in low-income countries also include unemployment and level of education due to the disparity in socioeconomic status [20].” Discussion 1. The antibiotic use as a risk factor for SSI is interesting but controversial. In fact, although many guidelines suggest to limit the use of the antibiotic prophylaxis at the day of the surgery, often antibiotics are prescribed several days before and after the surgical day. In my opinion Authors should give a possible explanation for this very important result possibly based on their data. Although the data regarding the timing and administration of surgical antibiotic prophylaxis were not available for this study, the reviewer’s comment led us to further investigate the relationship between the occurrence of SSI and the time between J01 antibiotics prescription time and surgery. The occurrence of SSI seems to vary for different times between antibiotics prescription and surgery (Fig 1), but hypotheses regarding this relationship should be evaluated using case-control studies with specific data regarding the reason for the prescription, the type of antimicrobials and the timing of the administration thereof. Fig 1. The occurrence of SSI for the time between the J01 antibiotics prescription start time and the start time of the surgery by decile. m, minutes; h, hours; d, days; #SSI, number of SSI occurrences; %SSI, percentage of SSI occurrences. 1The vertical axis starts at 75% to increase visibility. 2The horizontal axis stipulates the endpoints of the respective deciles of the distribution of the time between prescription and surgery. We added the following text to the discussion section to further share our insight with the readers: L280 – L283: “Systemic antibiotics are typically prescribed to stabilise patients before undergoing surgery. A possible explanation for the increased occurrence of SSI associated with antimicrobials prescribed before surgery could be that these patients were not completely stabilised before surgery which increased their risk of SSI.” 2. Did any data regarding the reason for surgical procedures were available? It is widely accepted that the cause of surgical procedure (infection, cancer, prosthetic implantation, etc) and the general clinical condition of patient (immunocompromised, severely undernourished, etc) are significant predictors of SSI. If these information are not available, this point should be included among limitations. We were hoping to include this information in the study but soon realised that these data were only available in free text field information, and there was no way to extract these data efficiently. We added the following sentence to the Limitations section: L288 – L290: “Surgeries were aggregated into three broad groups of surgical procedures which serve as a proxy for the reason for surgery but leads to the loss of information regarding the exact reasons for the surgery.” L294-295: “A comprehensive list of variables related to the nutritional and immunological alterations of the patients was not included in the analyses as they were not available from the data.” Reviewer #2: Methods 1. line 93: I think that could be useful to clarify how the nosocomial infection index was obtained, in particular which parameters where included to determine it. Thank you for bringing this to our attention. The references to the two articles which describe the nosocomial infection index, used as outcome variables in our study, are now provided immediately after the algorithm is mentioned for the first time. We also now refer to Streefkerk et al. in the text to make this referral clearer. 2. Line 192-205: I think that this paragraph should be removed. It appears too technical and probably not necessary for the purpose of the article. This paragraph referred to was added as supplementary material (S2 Formulae) instead. Discussion 1. Lines 240-241: when you talk about antibiotic usage before surgery do you refer to their use in a broad sense or there are particular class of antibiotics related to a major risk? It could be interesting to examine which classes are related to a major risk for SSI. Antibiotics in J01 Anatomical Therapeutic Chemical were used this study. This definition is specified in the variable definition table, but the legend was not complete. We agree with the reviewer that delving deeper into the subclasses of antibiotics is of great importance, although not in the scope of this study. The following changes were made to the manuscript: L101-103: The following text was added to the methods section where the data are described: “Data regarding the prescription of antimicrobials, in the J01 class of the Anatomical Therapeutic Chemical (ATC) classification system [28], were also included.” L161-L162: The following text was to the legend of the variable definition table: “ATC, Anatomical Therapeutic Chemical; WHO, World Health Organization.” 2. Lines 256-257: there is a repetition, you just defined the general risk factors in lines 225-228 Thank you, we have removed the repetition. Submitted filename: Response to Reviewers.docx Click here for additional data file. 7 Oct 2020 Risk factors for surgical site infections using a data-driven approach PONE-D-20-14495R1 Dear Dr. Johan, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Francesco Di Gennaro Academic Editor PLOS ONE Additional Editor Comments (optional): Dear Authors congratulations! Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) Reviewer #2: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Mariani Michele Fabiano 9 Oct 2020 PONE-D-20-14495R1 Risk factors for surgical site infections using a data-driven approach Dear Dr. van Niekerk: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Francesco Di Gennaro Academic Editor PLOS ONE
  41 in total

1.  Risk factors for incisional and organ space surgical site infections after liver resection are different.

Authors:  Takashi Kokudo; Emilie Uldry; Nicolas Demartines; Nermin Halkic
Journal:  World J Surg       Date:  2015-05       Impact factor: 3.352

2.  Epidemiology and outcome of major postoperative infections following cardiac surgery: risk factors and impact of pathogen type.

Authors:  Luke F Chen; Jean Marie Arduino; Shubin Sheng; Lawrence H Muhlbaier; Zeina A Kanafani; Anthony D Harris; Thomas G Fraser; Keith Allen; G Ralph Corey; Vance G Fowler
Journal:  Am J Infect Control       Date:  2012-05-19       Impact factor: 2.918

3.  Risk factors for sternal wound and other infections in pediatric cardiac surgery patients.

Authors:  P A Mehta; C K Cunningham; C B Colella; G Alferis; L B Weiner
Journal:  Pediatr Infect Dis J       Date:  2000-10       Impact factor: 2.129

4.  Clinical and economic burden of surgical site infection in hysterectomy.

Authors:  Sanjoy Roy; Anuprita Patkar; Mehmet Daskiran; Ronald Levine; Piet Hinoul; Somesh Nigam
Journal:  Surg Infect (Larchmt)       Date:  2014-05-06       Impact factor: 2.150

5.  Patient-related risk factors for surgical site infection following eight types of gastrointestinal surgery.

Authors:  H Fukuda
Journal:  J Hosp Infect       Date:  2016-04-22       Impact factor: 3.926

6.  Risk factors for surgical site infections in abdominal surgery: a study in Nepal.

Authors:  Smith Giri; Bishnu P Kandel; Sushil Pant; Paleswan Joshi Lakhey; Yogendra P Singh; Pradeep Vaidya
Journal:  Surg Infect (Larchmt)       Date:  2013-05-14       Impact factor: 2.150

7.  Pseudomonas aeruginosa Infection after Pancreatoduodenectomy: Risk Factors and Clinic Impacts.

Authors:  Jun-Feng Zhang; Hong-Yan Zhu; Yong-Wei Sun; Wei Liu; Yan-Miao Huo; De-Jun Liu; Jiao Li; Rong Hua
Journal:  Surg Infect (Larchmt)       Date:  2015-08-03       Impact factor: 2.150

8.  Thrombocytosis Is a Risk Factor for Surgical Site Infections after Colon Resection: A Prospective Observational Study.

Authors:  Samantha McKenzie Stancu; Florin Iordache
Journal:  Surg Infect (Larchmt)       Date:  2018-09-26       Impact factor: 2.150

Review 9.  Patient, Surgery, and Hospital Related Risk Factors for Surgical Site Infections following Total Hip Arthroplasty.

Authors:  Georgios Triantafyllopoulos; Ottokar Stundner; Stavros Memtsoudis; Lazaros A Poultsides
Journal:  ScientificWorldJournal       Date:  2015-05-14

10.  Risk factors for postoperative surgical site infections in patients with Crohn's disease receiving definitive bowel resection.

Authors:  Song Liu; Ji Miao; Gefei Wang; Meng Wang; Xiuwen Wu; Kun Guo; Min Feng; Wenxian Guan; Jianan Ren
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

View more
  1 in total

1.  Incidence of surgical site infections after cervical spine surgery: results of a single-center cohort study adhering to multimodal preventive wound control protocol.

Authors:  Vera Spatenkova; Ondrej Bradac; Zuzana Mareckova; Petr Suchomel; Jan Hradil; Eduard Kuriscak; Milada Halacova
Journal:  Eur J Orthop Surg Traumatol       Date:  2022-09-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.